Literature DB >> 15037708

Prognostic value of the MIB-1 labeling index for central neurocytomas.

Dirk Rades1, Steven E Schild, Fabian Fehlauer.   

Abstract

Although central neurocytomas are generally described as benign CNS lesions, malignant behavior including craniospinal dissemination and tumor-related death may occur. This meta-analysis was performed to investigate the prognostic value of the MIB-1 labeling index. Data were obtained not from the literature alone but also from contact with the authors. The data suggested an MIB-1 index score of >3% to be associated with a worse prognosis for local control (p < 0.0001) and survival (p = 0.0004).

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15037708     DOI: 10.1212/01.wnl.0000115392.21898.e3

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  20 in total

Review 1.  Neurocytoma: a comprehensive review.

Authors:  Mehar Chand Sharma; Prabal Deb; Suash Sharma; Chitra Sarkar
Journal:  Neurosurg Rev       Date:  2006-08-29       Impact factor: 3.042

2.  Primary disseminated central neurocytoma: cytological and MRI evidence of tumor spread prior to surgery.

Authors:  Hoan Tran; Rafael Medina-Flores; Lisa A Cerilli; Jeremy Phelps; Fa-Chyi Lee; Gene Wong; Paul Turner
Journal:  J Neurooncol       Date:  2010-03-30       Impact factor: 4.130

3.  Clinical course of central neurocytoma with malignant transformation-an indication for craniospinal irradiation.

Authors:  Petra Mozes; Erika Szanto; Laszlo Tiszlavicz; Pal Barzo; Adrienne Cserhati; Emese Fodor; Katalin Hideghety
Journal:  Pathol Oncol Res       Date:  2013-10-12       Impact factor: 3.201

Review 4.  Gamma knife radiosurgery of recurrent atypical neurocytoma. Case report and review of the literature.

Authors:  R Wolff; V Seifert; A Mack; J Steinbach; C Rödel; R Heyd
Journal:  Strahlenther Onkol       Date:  2012-05-23       Impact factor: 3.621

Review 5.  Treatment recommendations for the various subgroups of neurocytomas.

Authors:  Dirk Rades; Steven E Schild
Journal:  J Neurooncol       Date:  2006-03-31       Impact factor: 4.130

6.  Well-differentiated neurocytoma: what is the best available treatment?

Authors:  Dirk Rades; Fabian Fehlauer; Katrin Lamszus; Steven E Schild; Christian Hagel; Manfred Westphal; Winfried Alberti
Journal:  Neuro Oncol       Date:  2005-01       Impact factor: 12.300

7.  Primary neurocytoma of the spinal cord: a case report and review of literature.

Authors:  Suash Sharma; Chitra Sarkar; Shailesh Gaikwad; Ashish Suri; Mehar C Sharma
Journal:  J Neurooncol       Date:  2005-08       Impact factor: 4.130

8.  Clinical, radiological, pathological and prognostic aspects of intraventricular oligodendroglioma: comparison with central neurocytoma.

Authors:  Xiang Xiao; Jun Zhou; Jun Wang; Lei Yang; Chunhong Wang; Yikai Xu; Yuankui Wu
Journal:  J Neurooncol       Date:  2017-09-12       Impact factor: 4.130

9.  Interphase cytogenetics for 1p19q and t(1;19)(q10;p10) may distinguish prognostically relevant subgroups in extraventricular neurocytoma.

Authors:  Fausto J Rodriguez; Renan A Mota; Bernd W Scheithauer; Caterina Giannini; Hilary Blair; Kent C New; Kevin J Wu; Dennis W Dickson; Robert B Jenkins
Journal:  Brain Pathol       Date:  2008-08-15       Impact factor: 6.508

10.  MIB-1 labeling index predicts recurrence in intraventricular central neurocytomas.

Authors:  Gurvinder Kaur; Ari J Kane; Michael E Sughrue; Michael Oh; Michael Safaee; Matthew Sun; Terik Tihan; Michael W McDermott; Mitchel S Berger; Andrew T Parsa
Journal:  J Clin Neurosci       Date:  2012-11-05       Impact factor: 1.961

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.